Education, Science, Technology, Innovation and Life
Open Access
Sign In

Research Progress on Cytokine-Mediated Fibrosis in Intrauterine Adhesions

Download as PDF

DOI: 10.23977/medsc.2026.070312 | Downloads: 1 | Views: 100

Author(s)

Lin Jin 1, Xu Ding 2, Yanhong Huang 2

Affiliation(s)

1 Shaanxi University of Chinese Medicine, Xianyang, Shaanxi, 712046, China
2 Xi'an International Medical Center Hospital, Xi'an, Shaanxi, 710100, China

Corresponding Author

Yanhong Huang

ABSTRACT

Intrauterine Adhesion (IUA) is a common intrauterine trauma disease in gynecology. Clinically, it mainly presents as amenorrhea, reduced menstrual flow, periodic abdominal pain, infertility, and recurrent miscarriage, seriously damaging the reproductive health of women of childbearing age. Recent studies have confirmed that immune inflammation imbalance is the core initiating mechanism mediating the occurrence and development of intrauterine adhesions. Cytokines, as the core regulatory mediators of the immune microenvironment, can participate in the transformation from physiological repair to pathological fibrosis after uterine endometrium injury by regulating the inflammatory cascade reaction, polarization of immune cells, activation of fibroblasts, and deposition of extracellular matrix. This article systematically reviews the mechanisms of normal intrauterine immune homeostasis and immune imbalance after injury, and summarizes the regulatory roles of various immune factors such as pro-inflammatory factors, anti-inflammatory factors, and chemokines in intrauterine adhesions and their downstream signaling pathways. The aim is to provide theoretical references for in-depth research on the mechanism of intrauterine adhesions and precise targeted immunotherapy.

KEYWORDS

Intrauterine adhesions; Endometrial injury; Immune factors; Inflammatory response; Fibrosis

CITE THIS PAPER

Lin Jin, Xu Ding, Yanhong Huang. Research Progress on Cytokine-Mediated Fibrosis in Intrauterine Adhesions. MEDS Clinical Medicine (2026). Vol. 7, No. 3, 87-93. DOI: http://dx.doi.org/10.23977/medsc.2026.070312.

REFERENCES

[1] Jiang J F, You H, Zhao X, et al. Chinese Expert Consensus on Integrated Traditional Chinese and Western Medicine Diagnosis and Treatment of Intrauterine Adhesions (2024 Edition)[J]. Chinese Journal of Practical Gynecology and Obstetrics, 2024, 40(8): 819-825. DOI:10.19538/j.fk2024080111. 
[2] Jackson MM, Edmonds KA, Jones-Cox CE. Strategies to avoid recurrence of intrauterine adhesions after hysteroscopic adhesiolysis. Curr Opin Obstet Gynecol. 2025 Aug 1;37(4):241-246. doi: 10.1097/GCO.0000000000001029. Epub 2025 Apr 1. PMID: 40172533.  
[3] Shen M H, Yao T. Practical Methods and Efficacy Evaluation of Endometrial Injury Repair[J]. Chinese Journal of Practical Gynecology and Obstetrics, 2026, 42(3): 272-276. DOI:10.19538/j.fk2026030104.
[4] He Y E, Liang Y C, Cai H, et al. Research Progress on the Role of Cellular Transformation in the Development of Endometriosis Fibrosis[J]. Chinese Journal of New Clinical Medicine, 2026, 19(5): 619-623.
[5] Chen F, Duan H. Research Progress on Endometrial Injury Repair[J]. Chinese Journal of Family Planning & Obstetrics and Gynecology, 2026, 18(1): 7-10. 
[6] Yu X, Zhang Y, Shi LJ, Wang H. Dual Role of the Endometrial Microbiome-Immune Axis: From Endometrial Homeostasis to Reproductive Disorders. Int J Womens Health. 2026 Feb 11;18:559370. doi: 10.2147/IJWH.S559370. PMID: 41710143; PMCID: PMC12912184.
[7] Yan X, Jiao J, Wang X. The pathogenesis, diagnosis, and treatment of chronic endometritis: a comprehensive review. Front Endocrinol (Lausanne). 2025 Jun 12;16:1603570. doi: 10.3389/fendo.2025.1603570. PMID: 40575265; PMCID: PMC12197937.
[8] Groover MK, Richmond JM. Potential therapeutic manipulations of the CXCR3 chemokine axis for the treatment of inflammatory fibrosing diseases. F1000Res. 2020 Oct 5;9:1197. doi: 10.12688/f1000research.26728.1. PMID: 33145014; PMCID: PMC7590900.
[9] Zhou Z H, Zhao G F, Hu Y L. FOXM1 Regulates Inflammatory Response in Patients with Intrauterine Adhesions via NF-κB Signaling Pathway[J]. Progress in Obstetrics and Gynecology, 2025, 34(5): 362-367. DOI:10.13283/j.cnki.xdfckjz.2025.05.004.
[10] Patiman M, Fan Y J. Etiological Research of Intrauterine Adhesions and Discussion on Preventive Measures[J]. Chinese Journal of Family Planning & Obstetrics and Gynecology, 2024, 16(7): 32-35.
[11] Antar SA, Ashour NA, Marawan ME, Al-Karmalawy AA. Fibrosis: Types, Effects, Markers, Mechanisms for Disease Progression, and Its Relation with Oxidative Stress, Immunity, and Inflammation. International Journal of Molecular Sciences. 2023; 24(4):4004. https://doi.org/10.3390/ijms24044004 
[12] Zitong Z ,Xuetao M ,Yi Z , et al.Research progress in the correlation between reproductive tract microbiota and intrauterine adhesion[J]. Journal of Central South University(Medical Sciences) 2022, 47(11): 1495-1503. DOI:10.11817/J.ISSN.1672-7347.2022.220130.
[13] Yao S, Zhou Z, Wang L, Lv H, Liu D, Zhu Q, Zhang X, Zhao G, Hu Y. Targeting endometrial inflammation in intrauterine adhesion ameliorates endometrial fibrosis by priming MSCs to secrete C1INH. iScience. 2023 Jun 24;26(7):107201. doi: 10.1016/j.isci.2023.107201. PMID: 37456855; PMCID: PMC10344943.
[14] Jia X, Zhang Y, Cai H. Macrophages, fibrosis, and intrauterine adhesions: Cellular interactions and pathophysiological implications. Life Sci. 2026 Mar 15;389:124242. doi: 10.1016/j.lfs.2026.124242. Epub 2026 Jan 30. PMID: 41621787.
[15] Qin Z, Yu Q, Long Y. Unveiling the Pathological Landscape of Intrauterine Adhesion: Mechanistic Insights and Exosome-Biomaterial Therapeutic Innovations. Int J Nanomedicine. 2025 Aug 5;20:9667-9694. doi: 10.2147/IJN.S527637. PMID: 40785949; PMCID: PMC12335249.
[16] Zhao G, Hu Y. Mechanistic insights into intrauterine adhesions[J]. Seminars in immunopathology, 2024, 47(1): 3.DOI:10.1007/S00281-024-01030-9.
[17] Ren, T. T., Zhu, C. C., Luo, Y. H. Research progress of mesenchymal stem cells combined with hydrogel in the treatment of intrauterine adhesions. Chinese Journal of Clinical Pharmacology and Therapeutics. https://link.cnki.net/urlid/34.1206.r.20260617.1353.002
[18] Li G C, Zhai C, Zhang X X, et al. Research Progress of Transforming Growth Factor β1 in Intrauterine Adhesions[J]. International Journal of Reproductive Health/Family Planning, 2023, 42(1): 83-88.
[19] Wang S, Lin S L, Duan H. Research Progress on the Role of Chemokines in the Pathogenesis of Endometriosis[J]. Chinese Journal of Minimally Invasive Surgery, 2020, 20(7): 644-648. 
[20] Greenman R, Weston CJ. CCL24 and Fibrosis: A Narrative Review of Existing Evidence and Mechanisms. Cells. 2025 Jan 13;14(2):105. doi: 10.3390/cells14020105. PMID: 39851534; PMCID: PMC11763828.
[21] Wang N, Liu B, Zhang Y, Man X, Jiang R, Yao L, Dong X, Guo M, Sun J, Bi J. Chemokine CCL21 promotes the pathological progression of endometriosis by regulating inflammatory cytokine expression and activating the NF-κB signaling pathway. Int Immunopharmacol. 2026 Jun 29;186:117079. doi: 10.1016/j.intimp.2026.117079. Epub ahead of print. PMID: 42372587.
[22] Shen D Y, Qi C, Shen C, et al. Research Progress of Autophagy in the Progression of Intrauterine Adhesions[J]. Reproductive Medicine Journal, 2026, 35(3): 405-410. 
[23] Gou D, Cai X, He H, Chi Y. Understanding and treating intrauterine adhesions: Insights into molecular mechanisms and innovative therapies. Int J Gynaecol Obstet. 2026 Jun;173(3):1265-1283. doi: 10.1002/ijgo.70755. Epub 2025 Dec 23. PMID: 41432216.
[24] Hou G L, Yi H W, Li W, et al. Study on Differential Gene Transcription Expression Between Normal Endometrium and Endometrium with Intrauterine Adhesions in Women of Childbearing Age[J]. Journal of Shandong Medical College, 2026, 48(3): 1-4+109+101.
[25] Liang C L, Liang J Y, Luo M, et al. Effects of Intrauterine Perfusion of Platelet-Rich Plasma on Endometrial Thickness, Inflammatory Factors and Pregnancy Status in Patients Undergoing Hysteroscopic Surgery for Intrauterine Adhesions[J]. Journal of Clinical and Experimental Medicine, 2026, 25(4): 404-408. 
[26] Fan M ,Kuang C ,Ming Y , et al.Guizhi Fuling Pills against Intrauterine Adhesion via the TNF/AKT1/NFKBIA Axis in Inflammatory Response[J].Journal of Pharmaceutical Innovation,2026,21(5):506-506.DOI:10.1007/S12247-026-10708-6. 
[27] Chen Q ,Jiang C ,Ren L , et al.L26/P-366 Induced pluripotent stem cell-derived exosomes ameliorate endometrial fibrosis and immune dysregulation in intrauterine adhesion[J]. Human Reproduction, 2026, 41(Supplement_1): deag083.701-deag083.701. DOI:10.1093/HUMREP/DEAG083.701.

Downloads: 12224
Visits: 1114501

Sponsors, Associates, and Links


All published work is licensed under a Creative Commons Attribution 4.0 International License.

Copyright © 2016 - 2031 Clausius Scientific Press Inc. All Rights Reserved.